Median Diagnostics Inc. (XKON:233250)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,970
+470 (4.48%)
At close: Jan 28, 2026
-31.44%
Market Cap18.85B
Revenue (ttm)7.86B +40.4%
Net Income-567.58M
EPS-496.00
Shares Out1.75M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1
Average Volume67
Open10,970
Previous Close10,500
Day's Range10,970 - 10,970
52-Week Range9,760 - 16,600
Beta0.24
RSI46.77
Earnings Daten/a

About Median Diagnostics

Median Diagnostics Inc. manufactures and sells veterinary medicines and diagnostic reagents. The company’s products include PCR sets for pigs, ruminants, poultry, equine, canine and feline, and shrimps; rapid kits for pigs, ruminants, poultry, canine, feline, erwinia amylovora, and bovine pregnancy; ELISA for pigs, ruminants, avians, and horses; standard reagents, including AGID, HI, and FA; and antigen/antibody, including antibodies for veterinary diagnostics, and antibodies and antigens for human diagnostics. It also offers mouse and rat path... [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1999
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 233250
Full Company Profile

Financial Performance

Financial Statements